Contact
Please use this form to send email to PR contact of this press release:
Paras Biopharm Successfully Develops Cytofold StructQuant Tech for Cytoplasmic Disulphide Formation
TO:
Mark Jackson
mark.jackson@parasbiopharma.com
44 2905993